A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study

Authors:

Abstract
No abstract available
Funding Information
  • Pfizer Inc.

This publication has 23 references indexed in Scilit: